Article Sidebar
Views pdf: 89
ASSOCIATION BETWEEN METABOLIC SYNDROME AND LUMBAR SPINAL STENOSIS AT THE UNIVERSITY MEDICAL CENTER HO CHI MINH CITY
Main Article Content
Abstract
Lumbar spinal stenosis is one of the most common spinal disorders in patients. In addition, metabolic syndrome is considered a potential risk factor that may contribute to the increased prevalence of lumbar spinal stenosis. Therefore, identifying the relationship between metabolic syndrome and lumbar spinal stenosis may help optimize treatment and patient care. Objective: To determine the prevalence of metabolic syndrome among patients with lumbar spinal stenosis and to examine the association between lumbar spinal stenosis and metabolic syndrome. Methods: A descriptive cross-sectional study was conducted on 88 patients diagnosed with lumbar spinal stenosis. Results: The prevalence of metabolic syndrome among patients with lumbar spinal stenosis was 55.7%. The study found statistically significant differences in history of diabetes, systolic and diastolic blood pressure, waist circumference, body mass index, HDL-cholesterol, triglycerides, glucose, and HbA1c between the two groups. There was a strong correlation between these factors and the presence of metabolic syndrome in patients with lumbar spinal stenosis. Conclusion: Patients with lumbar spinal stenosis are at high risk of developing metabolic syndrome. Therefore, effective management of the components of metabolic syndrome is essential in patients with lumbar spinal stenosis.
Article Details
Keywords
Lumbar spinal stenosis, metabolic syndrome
References
2. Ferreira Mota Colares SP, Colares GM, Freire de Carvalho J, Ewerton Maia Rodrigues C. High Prevalence of Metabolic Syndrome in Patients with Lumbar Spinal Stenosis: Association with Diabetes and Elevated Body Mass Index. Isr Med Assoc J. 2021;23(12):766-772.
3. Kreiner DS, Shaffer WO, Baisden JL, et al. An evidence-based clinical guideline for the diagnosis and treatment of degenerative lumbar spinal stenosis (update). Spine J. 2013;13(7):734-743. doi:10.1016/j.spinee.2012.11.059
4. Eckel RH, Cornier MA. Update on the NCEP ATP-III emerging cardiometabolic risk factors. BMC Med. 2014;12:115. Published 2014 Aug 26. doi:10.1186/1741-7015-12-115
5. Gandhi R, Woo KM, Zywiel MG, Rampersaud YR. Metabolic syndrome increases the prevalence of spine osteoarthritis. Orthop Surg. 2014;6(1): 23-27. doi:10.1111/os.12093
6. Asadian L, Haddadi K, Aarabi M, Zare A. Diabetes Mellitus, a New Risk Factor for Lumbar Spinal Stenosis: A Case-Control Study. Clin Med Insights Endocrinol Diabetes. 2016;9:1-5. Published 2016 May 5. doi:10.4137/CMED.S39035
7. Uesugi K, Sekiguchi M, Kikuchi S, Konno S. Relationship between lumbar spinal stenosis and lifestyle-related disorders: a cross-sectional multicenter observational study. Spine (Phila Pa 1976). 2013;38(9): E540-E545. doi:10.1097/BRS. 0b013e31828a2517
8. Kurunlahti M, Tervonen O, Vanharanta H, Ilkko E, Suramo I. Association of atherosclerosis with low back pain and the degree of disc degeneration. Spine (Phila Pa 1976). 1999;24(20):2080-2084. doi:10.1097/00007632-199910150-00003
9. Maeda T, Hashizume H, Yoshimura N, et al. Factors associated with lumbar spinal stenosis in a large-scale, population-based cohort: The Wakayama Spine Study. PLoS One. 2018;13(7): e0200208. Published 2018 Jul 18. doi:10.1371/journal.pone.0200208
10. Knutsson B, Sandén B, Sjödén G, Järvholm B, Michaëlsson K. Body Mass Index and Risk for Clinical Lumbar Spinal Stenosis: A Cohort Study. Spine (Phila Pa 1976). 2015;40(18):1451-1456. doi:10.1097/BRS.0000000000001038